Mellemgaard A, Lindblad P, Schlehofer B, Bergström R, Mandel J S, McCredie M, McLaughlin J K, Niwa S, Odaka N, Pommer W
Danish Cancer Society, Division of Cancer Epidemiology, Copenhagen.
Int J Cancer. 1995 Jan 27;60(3):350-4. doi: 10.1002/ijc.2910600313.
Although numerous studies have identified obesity or high relative weight as a risk factor for renal-cell cancer in women, the degree to which this effect is present in men remains unclear. A multicenter population-based case-control study concerning incident cases of histologically verified renal-cell cancer (n = 1,732) and age- and sex-matched controls (n = 2,309) was conducted in Australia, Denmark, Germany (2 centers), Sweden and the United States. Relative weight was estimated by the body mass index, and the association between this factor and other factors, such as height, physical activity and use of amphetamines, was measured by the relative risk estimated in logistic regression models. Body mass index was found to be a risk factor among women and, to a lesser extent, among men. A 3-fold increased risk (RR = 3.6, 95% CI = 2.3-5.7) was observed for women with a relative weight in the top 5% compared with those in the lowest quartile. Rate of weight change (estimated as weight change per annum in kilograms) appeared to be an independent risk factor among women but not among men. Physical activity and height were unrelated to risk of renal-cell cancer regardless of level of BMI, while use of amphetamines was associated with an increased risk among men, although no dose or duration effect was seen. Our findings verify the link between high relative weight and risk of renal-cell cancer, particularly among women. The mechanism that underlies this association is, however, still unclear, although the rate of weight change may play a role.
尽管众多研究已将肥胖或较高的相对体重确定为女性肾细胞癌的一个风险因素,但这种影响在男性中存在的程度仍不明确。在澳大利亚、丹麦、德国(两个中心)、瑞典和美国开展了一项基于人群的多中心病例对照研究,研究对象为经组织学证实的肾细胞癌新发病例(n = 1732)以及年龄和性别匹配的对照(n = 2309)。通过体重指数估算相对体重,并通过逻辑回归模型估算的相对风险来衡量该因素与其他因素(如身高、身体活动和苯丙胺使用情况)之间的关联。结果发现体重指数在女性中是一个风险因素,在男性中的影响程度较小。与体重处于最低四分位数的女性相比,相对体重处于前5%的女性风险增加了3倍(RR = 3.6,95% CI = 2.3 - 5.7)。体重变化率(以每年体重变化的千克数估算)在女性中似乎是一个独立的风险因素,而在男性中并非如此。无论体重指数水平如何,身体活动和身高与肾细胞癌风险均无关联,而苯丙胺的使用与男性风险增加有关,尽管未观察到剂量或持续时间效应。我们的研究结果证实了高相对体重与肾细胞癌风险之间的联系,尤其是在女性中。然而,这种关联背后的机制仍不清楚,尽管体重变化率可能起一定作用。